Therefore, we consider that brain AT1R and antioxidant properties of Nrf2 would be the novel therapeutic target to improve circulatory homeostasis via amelioration of baroreflex and volume tolerance in heart failure. The gene discussed is NFE2L2; the disease is heart failure.